Nine Square Therapeutics: Funding, Investors & Team (Oct 2026)
Nine Square Therapeutics, based in New York, is a company established in 2020 that focuses on the development of small-molecule treatments for degenerative movement disorders like Parkinson's disease and ALS, as well as non-degenerative disorders like essential tremor and dyskinesias. The company employs a combination of computational chemistry, biophysics, and computational biology, along with machine-learning-powered cell profiling platforms, to identify potential targets, optimize chemical compounds, and stratify patients.
Nine Square Therapeutics has raised $4.5M across 1 funding round on record, the most recent an undisclosed round of $4.5M announced in Sep 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nine Square Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Nine Square Therapeutics Funding Rounds
Nine Square Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Nine Square Therapeutics Funding Compared to Other Biotechnology Startups
Nine Square Therapeutics' latest round of $4.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nine Square Therapeutics in Biotechnology and New York
Companies Similar to Nine Square Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Nine Square Therapeutics Funding FAQs
What does Nine Square Therapeutics do?
Nine Square Therapeutics, based in New York, is a company established in 2020 that focuses on the development of small-molecule treatments for degenerative movement disorders like Parkinson's disease and ALS, as well as non-degenerative disorders like essential tremor and dyskinesias. The company employs a combination of computational chemistry, biophysics, and computational biology, along with machine-learning-powered cell profiling platforms, to identify potential targets, optimize chemical compounds, and stratify patients.
How much funding has Nine Square Therapeutics raised?
Nine Square Therapeutics has raised $4.5M across 1 round on record. The most recent is an undisclosed round of $4.5M announced in Sep 2023.
When did Nine Square Therapeutics last raise funding?
Nine Square Therapeutics' most recent funding round on record is an undisclosed round of $4.5M, announced in Sep 2023.
Who founded Nine Square Therapeutics?
FundedIQ lists Steven Altschuler (Founder) at Nine Square Therapeutics.
Where is Nine Square Therapeutics headquartered?
Nine Square Therapeutics is based in New York, United States.
How many employees does Nine Square Therapeutics have?
Nine Square Therapeutics is in the 101-250 employee band.
How does Nine Square Therapeutics' funding compare to other Biotechnology startups?
Nine Square Therapeutics' latest round of $4.5M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nine Square Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nine Square Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.